Evercore ISI Group Rates Ventas (VTR) buy, $96 Price Target
Evercore ISI maintained its buy rating for Ventas, Inc. with a $96 price target, a 8.11% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Evercore ISI Group rated Ventas, Inc. ($VTR) "buy" with a $96 price target on July 1, 2026.
Since the rating, $VTR is up 3.1% after 1 week, up 4.3% after 1 month and down 3.6% to date (from the $89.11 close on Jul 1, 2026).
VTR
Ventas, Inc.
Key Points
- Evercore ISI reiterated its buy rating on Ventas, Inc. (VTR) with a $96 target on July 1, 2026.
- Evercore ISI Group's $96 price target implies 8.11% upside from Ventas, Inc.'s ($VTR) current $88.80 share price.
- Ventas shares traded at $88.8 on Wednesday, with a market cap of about $43.17 billion and a P/E ratio of 161.5.
- Recent insider transactions include purchases by Michael Embler and Melody Barnes, and analysts maintain positive outlooks.
Get $VTR trade alerts by text
We text you when insiders, Congress or big funds trade $VTR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Ventas, Inc. alert may contain errors. Disclosures
Evercore ISI Group reiterated its buy rating on Ventas, Inc. (NYSE: VTR) on July 1, 2026, maintaining a price target of $96. Shares of Ventas traded near $88.8 on Wednesday.
Evercore ISI Group vs. the S&P 500
Hypothetical returns from Evercore ISI Group's disclosed trades, not real profit or advice. How we model this.
Ventas, Inc. Stock Up 2.4%
Shares of NYSE:VTR traded around $88.8 on Wednesday. Ventas, Inc., a real estate investment trust specializing in healthcare facilities, boasts a market cap of approximately $43.17 billion. The company has a P/E ratio of 161.5 and a forward P/E of 104.9, with a beta of 0.734. Over the past year, the stock has ranged from $61.93 to $91.06. Its 50-day moving average stands at $85.39, while the 200-day moving average is $79.88.
$VTR price target
Ventas, Inc. daily closes and this analyst's $96 target. Not advice.
Analysts Set New Price Targets
On July 1, 2026, Evercore ISI Group maintained its buy rating for Ventas, Inc. with a $96 price target. Other analysts have also shown confidence in the stock. For instance, on June 18, 2026, Scotiabank maintained a hold rating with an $88 target, while Raymond James reinstated a buy rating with a $94 target on June 17, 2026. As of now, the consensus among analysts is a buy rating, with a mean price target of $96.57 based on 21 analyst opinions.
Insider Buying and Selling at Ventas, Inc.
Recent insider activity at Ventas includes several transactions. On June 3, 2026, Michael Embler bought 2,500 shares at an average price of $78.81. Earlier, on May 13, 2026, Melody Barnes purchased 2,047 shares at $90.35, alongside Matthew Lustig and Sumit Roy, who also bought the same number of shares on the same date. These transactions were not planned under a Rule 10b5-1 trading plan.
About Ventas, Inc.
Ventas, Inc. is a major player in the real estate investment trust sector, focusing on healthcare facilities. Headquartered in Chicago, Illinois, the company is led by CEO Debra A. Cafaro. With around 1,400 properties across North America and the UK, Ventas operates a significant portfolio that includes senior housing communities, outpatient medical buildings, and research centers. The company aims to support the aging population by providing environments that promote health and longevity.
Bottom Line
Evercore ISI's reiteration of its buy rating for Ventas, Inc. reflects continued confidence in the company's prospects. With its strong market position in healthcare real estate, Ventas remains an essential player in the sector. Investors should note that 13F filings and analyst ratings reflect past positions and opinions, which may not represent current or future performance.
Related Filing Alerts
Source: Evercore ISI Group's rating change on $VTR (Jul 1, 2026). Written by software, not financial advice. How we make alerts